Skip to ContentSkip to Navigation
Practical matters How to find us prof. dr. A.L.W. (Anke) Huckriede

Publications

Ad26.COV2.S priming provided a solid immunological base for mRNA-based COVID-19 booster vaccination

Analyzing the immunogenicity of bivalent booster vaccinations in healthcare workers: The SWITCH ON trial protocol

An Efficient UV-C Disinfection Approach and Biological Assessment Strategy for Microphones

Assessing the Immunomodulatory Effect of Size on the Uptake and Immunogenicity of Influenza- and Hepatitis B Subunit Vaccines In Vitro

Circulating adipokine levels and COVID-19 severity in hospitalized patients

Durability of immune responses after boosting in Ad26.COV2.S-primed healthcare workers

Een vooruitblik op covid-19-vaccinatie en -behandeling

Immunogenicity 5-months after homologous or heterologous booster vaccination in Health Care Workers primed with Ad26.COV2.S

Immunogenicity and Reactogenicity of Vaccine Boosters after Ad26.COV2.S Priming

Intradermal Administration of Influenza Vaccine with Trehalose and Pullulan-Based Dissolving Microneedle Arrays

Read more

Press/media

Kwart van de mensen haalt neus op voor booster: 'Erg teleurstellend'

Na Janssen-vaccinatie mRNA-vaccins meest effectief als booster

Ruim 10 procent gevaccineerden neemt geen booster: 'Kan problemen opleveren'

Vaccinoloog: hopelijk houdt effect boosterprik lang aan

Geen Hollands Glorie in coronavaccins

Bescherming AstraZeneca-vaccin slijt snel, boosterprik nodig

Europees geneesmiddelenbureau oordeelt positief over ‘klassiek’ vaccin Novavax

Bescherming prik AstraZeneca en Janssen naar nul: hoe zit dat?

Six questions about the booster vaccines

Read more